## VTR: Ventas, Inc. - XLRE: Real Estate

### Executive Summary

No thesis match: MRS_20 -2.7% below STRENGTH zone (4.0-10.0%); PEG 1.74 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.6% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($73.83)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 5
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Trading Systems Reacting to (VTR) Volatility**
- Source: Stock Traders Daily | 20260103T220800 | Neutral | Relevance: 100%
- This article analyzes Ventas Inc. (NYSE: VTR), highlighting a weak near-term sentiment while suggesting potential long-term strength. It outlines various AI-generated trading strategies including position trading, momentum breakout, and risk hedging, with specific entry, target, and stop-loss levels. The analysis indicates a mid-channel oscillation pattern and offers an exceptional risk-reward setup targeting a 6.5% gain.

**2. Wall Street Is Suddenly Obsessed With Ventas Inc. – Is This Sleepy REIT Your Next Power Play?**
- Source: AD HOC NEWS | 20260105T031947 | Bullish | Relevance: 100%
- Ventas Inc. is gaining quiet attention on Wall Street as a real estate investment trust (REIT) focused on healthcare, senior housing, and life science properties. The company's strategy aligns with the growing megatrend of an aging population, making it an attractive option for long-term investors seeking steady income and growth through dividends. While not a flashy "meme stock," Ventas offers a strategic play for portfolios looking for stability and passive income.

**3. Wall Street Is Suddenly Obsessed With Ventas Inc. – Is This Sleepy REIT Your Next Power Play?**
- Source: AD HOC NEWS | 20260105T030847 | Somewhat-Bullish | Relevance: 100%
- Ventas Inc. (VTR) is gaining attention on Wall Street as a real estate investment trust (REIT) focused on healthcare, senior housing, and life science properties, capitalizing on the demographic trend of an aging global population. The company offers steady income through dividends and long-term growth potential, making it an attractive option for investors seeking stability and passive income rather than high-volatility, quick gains. While not a viral stock, it's favored by long-term and dividend-focused investors for its exposure to defensive market segments.

**4. Tangible book value per share of Ventas, Inc. – GETTEX:VEN**
- Source: TradingView — Track All Markets | 20260103T000853 | Neutral | Relevance: 100%
- This article provides information on the tangible book value per share of Ventas, Inc. (GETTEX:VEN). It presents a specific financial metric for the company, accessible through a market data platform. The content focuses solely on this financial data point for Ventas.

**5. Assessing Welltower (WELL) Valuation After Strong Long Term Returns And Premium Earnings Multiple**
- Source: Simply Wall Street | 20260105T222930 | Neutral | Relevance: 61%
- Welltower (WELL) is attracting investor attention due to its role in seniors and wellness housing and strong long-term stock performance. While a "narrative fair value" suggests the stock is 9.9% undervalued at $186.94 compared to a target of $207.38, its high P/E ratio of 133.6x (versus peers at 59.1x and the industry at 25.9x) indicates significant market optimism already priced in. Investors must decide whether to trust the growth narrative or the premium multiple.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 12 ($3.41M) |
| Sells | 11 ($22.87M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 62.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 2 |

**Top Holders:**
- Vanguard Group Inc: 15.7% (+2.5%)
- JPMORGAN CHASE & CO: 12.7% (+102.6%)
- Blackrock Inc.: 11.1% (+2.6%)
- State Street Corpora: 6.2% (+3.3%)
- FMR, LLC: 5.7% (+12.1%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-2.6% 5d) with bearish MACD, trend may be turning.
2. Heavy insider selling: $23M sold (11 transactions in 90 days).
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.74 elevated, pricing in significant growth expectations. Insider selling cluster ($22.9M in 90 days), potential headwind. Institutional flow bullish (7 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $35.9B |
| Beta | 0.80 |
| 52W Range | $56.68 - $81.89 |
| Short Interest | 4.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.74 |
| Forward P/E | 135.3 |
| Current P/E | 283.1 |
| YoY Growth | 109.3% |
| EPS Direction | FALLING |

### Technicals

MRS_20 deteriorating from -0.1% to -2.7% (-2.6% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 6.7pp (needs >4.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.10x) but short-term weakness (below SMA20). OFD pattern: -SLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -2.67% (CS: 15) | Weak |
| RSI_14 | 37.5 | Neutral |
| MACD Histogram | -0.44 | Bearish |
| vs SMA20 | 0.970x | Below |
| vs SMA50 | 0.987x | Below |
| vs SMA200 | 1.102x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $76.43
- **Stop Loss:** $73.83 (3.4% risk)
- **Target:** $79.03 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 442
- **Position Value:** $33,782.06
- **Portfolio %:** 33.78%
- **Risk Dollars:** $1,150.00
- **Risk Per Trade:** 1.15%
- **Modifiers:** L1 115% | L2 100% | Combined 1.15x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite. VIX remains calm at 14.9 (8th percentile) with positive yield curve (+65bps) and healthy breadth (59.2%), though elevated put/call ratio (1.27) suggests institutional hedging despite surface calm. Focus on quality with awareness of hedging activity divergence.*

### Earnings

**Next:** 2026-02-11 (Est: $0.09)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.05 | $0.12 | +141.9% |
| 2025Q2 | $0.14 | $0.15 | +10.4% |
| 2025Q1 | $0.07 | $0.10 | +35.8% |
| 2024Q4 | $0.05 | $0.13 | +156.6% |

---
*RULE-based L3 | 2026-01-07 09:36 | MRS_20*